Description
IPRALITE DUO RESPULES contains Ipratropium 500mcg + Levosalbutamol 1.25mg, a combination of two short-acting bronchodilators used to help relieve bronchospasm and improve airflow in appropriate obstructive airway conditions.
Ipratropium is a short-acting muscarinic antagonist (SAMA) and anticholinergic bronchodilator, while Levosalbutamol (Levalbuterol) is a selective short-acting beta-2 adrenergic receptor agonist (SABA). Together, these ingredients provide complementary bronchodilator activity through different receptor pathways.
Each 2mL respule of IPRALITE DUO RESPULES contains Ipratropium 500mcg + Levosalbutamol 1.25mg and is supplied in an 8×5×2.5mL pack. The formulation is intended for administration through a suitable nebulization system as directed by a healthcare professional.
Ipratropium helps reduce cholinergic-mediated bronchoconstriction by blocking muscarinic receptors in the airways. Levosalbutamol stimulates beta-2 receptors in bronchial smooth muscle, promoting relaxation and airway widening.
The Ipratropium 500mcg + Levosalbutamol 1.25mg uses depend on the patient’s respiratory condition and clinical assessment. The combination may be used for symptomatic relief of airflow limitation associated with conditions such as chronic obstructive pulmonary disease (COPD) and other bronchospastic airway conditions where combination bronchodilation is prescribed.
It should not be assumed to be appropriate for every respiratory symptom. Persistent, severe, or worsening breathing difficulty requires appropriate medical assessment.
For healthcare professionals, pharmacists, distributors, stockists, and procurement teams searching for Ipratropium 500mcg + Levosalbutamol 1.25mg respules, Ipratropium + Levosalbutamol nebulizer solution, or related pharmaceutical sourcing requirements, IPRALITE DUO RESPULES is a Sarian Healthcare pharmaceutical product supplied for professional healthcare and B2B pharmaceutical channels.
IPRALITE DUO RESPULES Composition
Each 2mL respule contains:
- Ipratropium – 500mcg
- Levosalbutamol – 1.25mg
Dosage Form: Respule / Nebulizer Solution
Pack Size: 8×5×2.5mL
Manufacturer: Sarian Healthcare
What Is Ipratropium 500mcg + Levosalbutamol 1.25mg Used For?
Ipratropium 500mcg + Levosalbutamol 1.25mg is a combination bronchodilator used to help relieve bronchospasm and improve airflow when both anticholinergic and beta-2 agonist bronchodilation are clinically appropriate.
The combination may be used in selected obstructive airway conditions, including COPD and other bronchospastic respiratory conditions, according to the treating physician’s assessment.
Ipratropium helps reduce cholinergic-mediated airway constriction, while Levosalbutamol relaxes bronchial smooth muscle through beta-2 receptor stimulation.
The appropriate indication, dosage, frequency, and duration of treatment should be determined by a qualified healthcare professional.
Key Ingredients and Their Functions
1. Ipratropium – 500mcg
Active Ingredient: Ipratropium
Strength: 500mcg per 2mL respule
Drug Class: Short-Acting Muscarinic Antagonist (SAMA) / Anticholinergic Bronchodilator
Therapeutic Category: Respiratory Bronchodilator
Primary Function: Reduces cholinergic-mediated bronchoconstriction
Ipratropium is the anticholinergic component of IPRALITE DUO RESPULES. It blocks muscarinic receptors in airway smooth muscle and reduces vagally mediated bronchoconstriction.
This action contributes to airway relaxation and improved airflow.
2. Levosalbutamol – 1.25mg
Active Ingredient: Levosalbutamol (Levalbuterol)
Strength: 1.25mg per 2mL respule
Drug Class: Short-Acting Beta-2 Adrenergic Receptor Agonist (SABA)
Therapeutic Category: Respiratory Bronchodilator
Primary Function: Relaxes bronchial smooth muscle
Levosalbutamol is the pharmacologically active R-enantiomer of salbutamol. It primarily stimulates beta-2 adrenergic receptors in bronchial smooth muscle.
Activation of these receptors increases intracellular cyclic AMP and promotes relaxation of bronchial smooth muscle, resulting in bronchodilation.
Key Benefits of IPRALITE DUO RESPULES
Complementary Bronchodilation
Ipratropium and Levosalbutamol work through different receptor pathways to promote airway relaxation.
Supports Improved Airflow
Bronchodilation can help reduce airflow limitation and relieve bronchospasm in appropriate respiratory conditions.
Dual Pharmacological Action
The combination provides both anticholinergic and beta-2 agonist bronchodilator activity within one formulation.
Nebulized Dosage Form
The respule formulation allows administration through a compatible nebulization device when prescribed by a healthcare professional.
Useful in Appropriate Obstructive Airway Conditions
The combination can be clinically useful when both short-acting muscarinic blockade and beta-2 agonist bronchodilation are indicated.
Convenient Fixed-Dose Combination
Two complementary bronchodilators are provided in a single respule formulation for prescribed nebulized treatment.
How Does Ipratropium 500mcg + Levosalbutamol 1.25mg Work?
Ipratropium 500mcg + Levosalbutamol 1.25mg produces bronchodilation through two complementary mechanisms.
Ipratropium is a short-acting muscarinic antagonist. It blocks muscarinic receptors, particularly M3 receptors, on airway smooth muscle. This reduces the effect of acetylcholine-mediated parasympathetic bronchoconstriction and helps relax the airways.
Levosalbutamol acts primarily as a beta-2 adrenergic receptor agonist. Activation of beta-2 receptors increases intracellular cyclic AMP through stimulation of adenylate cyclase. This promotes relaxation of bronchial smooth muscle and produces bronchodilation.
By targeting cholinergic bronchoconstriction and beta-2-mediated smooth-muscle relaxation simultaneously, the Ipratropium + Levosalbutamol mechanism of action provides complementary airway-opening effects.
The clinical response depends on the underlying respiratory condition, disease severity, prescribed treatment regimen, and individual patient factors.
Directions for Use
IPRALITE DUO RESPULES is intended for administration by nebulization through a suitable nebulizer device, as prescribed by a healthcare professional.
- Use the respule according to the instructions provided with the nebulizer and product packaging.
- Do not swallow the respule contents.
- Do not use the solution by an alternative route.
- Use the prescribed amount at the recommended frequency.
- Do not independently increase the dose or frequency.
- Avoid contact of the nebulized solution with the eyes.
- Do not mix the solution with other medicines in the nebulizer unless specifically instructed by a healthcare professional.
- Follow the prescribed treatment schedule.
- Do not discontinue regular therapy without medical advice.
- Dosage and treatment duration should be determined by the treating physician.
- If acute or worsening breathlessness does not improve with the prescribed treatment, seek urgent medical attention.
Possible Side Effects
Common Side Effects
Possible adverse effects associated with Ipratropium and Levosalbutamol may include:
- Dry mouth
- Headache
- Dizziness
- Cough or throat irritation
- Tremor
- Nervousness or restlessness
- Palpitations
- Increased heart rate
- Nausea
- Muscle cramps
Not every patient experiences these effects, and their severity can vary.
Important Adverse Reactions
Important reactions requiring medical attention may include:
- Paradoxical bronchospasm or worsening breathing immediately after inhalation
- Significant palpitations or cardiac rhythm disturbances
- Hypersensitivity reactions, including rash, swelling, or difficulty breathing
- Eye pain, blurred vision, or visual halos if nebulized medication reaches the eyes
- Urinary retention, particularly in susceptible individuals
- Significant hypokalemia with excessive beta-2 agonist exposure
Seek immediate medical attention for severe breathing difficulty, facial or throat swelling, severe chest symptoms, or other serious reactions.
Safety Information
Use Ipratropium 500mcg + Levosalbutamol 1.25mg under appropriate medical supervision.
- Do not use in patients with known hypersensitivity to Ipratropium, Levosalbutamol, atropine-like compounds, or any formulation component.
- Use caution in patients with narrow-angle glaucoma because Ipratropium reaching the eyes may increase intraocular pressure.
- Patients with prostatic enlargement or bladder-outflow obstruction may require additional caution because anticholinergic effects can contribute to urinary retention.
- Patients with cardiovascular disease, arrhythmias, hypertension, hyperthyroidism, diabetes, or seizure disorders should inform their healthcare professional before treatment.
- Levosalbutamol can cause tremor, tachycardia, palpitations, and changes in serum potassium, particularly with excessive exposure.
- Concomitant use with other beta-2 agonists or anticholinergic bronchodilators should be reviewed by the treating physician.
- Beta-blockers may reduce or antagonize the bronchodilator effect of Levosalbutamol and should be considered carefully by the prescriber.
- Diuretics, corticosteroids, and other medicines that can lower potassium may increase the risk of hypokalemia with beta-2 agonists.
- MAO inhibitors and tricyclic antidepressants may enhance cardiovascular effects of beta-adrenergic agonists and require medical consideration.
- Pregnancy use should be based on clinical need and medical supervision.
- Consult a healthcare professional before use during breastfeeding.
- Appropriate clinical assessment may be required in patients with significant kidney or liver impairment.
- Pediatric patients should use this medicine only when specifically prescribed and with an age-appropriate nebulization system and medical supervision.
- Elderly patients may be more susceptible to cardiovascular, urinary, and anticholinergic adverse effects.
- Avoid allowing nebulized solution to enter the eyes. Patients using a face mask should ensure a proper fit.
- Do not drive or operate machinery if dizziness, tremor, visual disturbance, or other symptoms impair alertness or coordination.
- If wheezing or breathing difficulty worsens immediately after administration, discontinue treatment and seek urgent medical assessment.
Storage Instructions
Store IPRALITE DUO RESPULES in a cool, dry place away from direct sunlight and moisture.
Keep the product out of reach of children and follow the storage instructions printed on the product packaging.
Sarian Healthcare – Pharmaceutical Company in Gujarat
Sarian Healthcare is a pharmaceutical company focused on developing and providing healthcare products across different therapeutic categories. The company aims to build a growing pharmaceutical portfolio while maintaining a professional approach to product quality, supply, and business relationships.
Sarian Healthcare works with healthcare professionals, pharmacies, distributors, stockists, procurement teams, and other pharmaceutical business partners across different markets.
For businesses searching for a pharmaceutical company in Ahmedabad, pharma companies in Ahmedabad, or a pharma company in Changodar, Sarian Healthcare provides opportunities for pharmaceutical product sourcing and professional business collaboration.
Pharmaceutical Company in Ahmedabad and Changodar
Ahmedabad and Changodar are important pharmaceutical and healthcare hubs in Gujarat, with a strong ecosystem of pharmaceutical manufacturers, healthcare companies, distributors, suppliers, and related businesses.
Sarian Healthcare serves the requirements of the pharmaceutical market through its growing healthcare product portfolio and professional business approach.
Businesses searching for a pharmaceutical company in Ahmedabad can evaluate Sarian Healthcare based on its product portfolio, quality-focused approach, supply capabilities, and professional support.
For businesses looking for a pharma company in Changodar, Sarian Healthcare focuses on pharmaceutical products, professional coordination, and long-term relationships with healthcare and pharmaceutical business partners.
Pharmaceutical Manufacturers in Gujarat
Gujarat is an important pharmaceutical hub in India, supporting a broad ecosystem of pharmaceutical manufacturers, healthcare companies, distributors, suppliers, and related industries.
Businesses searching for pharmaceutical manufacturers in Gujarat commonly consider factors such as product quality, manufacturing capabilities, quality systems, regulatory requirements, product portfolio, supply consistency, and professional support.
Sarian Healthcare continues to develop its pharmaceutical product portfolio with a focus on quality and professional requirements.
Generic Medicine Company in Gujarat
The pharmaceutical industry continues to create opportunities for businesses seeking quality healthcare products across Gujarat and India.
As a generic medicine company in Gujarat, Sarian Healthcare focuses on building a diverse pharmaceutical portfolio for healthcare professionals, distributors, stockists, pharmacies, and other pharmaceutical business partners.
Businesses looking for a generic medicine company in Gujarat can evaluate Sarian Healthcare based on its product portfolio, quality-focused approach, supply capabilities, professional support, and long-term business potential.
Healthcare Companies in Ahmedabad
Ahmedabad has developed into an important center for pharmaceutical manufacturing, healthcare, distribution, and related industries.
The healthcare companies in Ahmedabad contribute to a broad ecosystem connecting pharmaceutical manufacturers, distributors, pharmacies, healthcare professionals, procurement teams, and suppliers.
Sarian Healthcare continues to expand its healthcare product portfolio while developing professional relationships within the pharmaceutical industry.
Pharma Distributors and Wholesale Opportunities
A dependable distribution network plays an important role in making pharmaceutical products available to pharmacies, healthcare institutions, stockists, and other markets.
Sarian Healthcare works toward developing professional relationships with pharma distributors, stockists, wholesalers, pharmacies, and healthcare product suppliers.
For businesses searching for pharma distributors in Ahmedabad, working with a dependable pharmaceutical company can support organized product sourcing and distribution.
Businesses researching pharmaceutical wholesale & distribution companies can evaluate potential partners based on product availability, portfolio strength, supply consistency, professional support, and business coordination.
Medicine Manufacturing Company in Ahmedabad
Ahmedabad and surrounding industrial regions form an important part of Gujarat’s pharmaceutical ecosystem.
Businesses searching for a medicine manufacturing company in Ahmedabad often evaluate factors such as product quality, manufacturing capabilities, supply consistency, regulatory requirements, product range, and professional pharmaceutical support.
Sarian Healthcare continues to focus on developing its pharmaceutical portfolio and supporting the requirements of healthcare professionals and pharmaceutical business partners.
Why Choose Sarian Healthcare as a Reliable Pharmaceutical Partner?
Selecting the right pharmaceutical partner is important for distributors, stockists, pharmacies, healthcare businesses, procurement teams, and pharmaceutical professionals.
Sarian Healthcare focuses on product quality, professional service, dependable supply, portfolio development, and long-term business relationships.
Growing Pharmaceutical Product Portfolio
Sarian Healthcare continues to expand its pharmaceutical product portfolio across different therapeutic categories, providing healthcare businesses and distribution partners with access to a wider range of products.
Quality-Focused Approach
Product quality is an important consideration when selecting a pharmaceutical partner. Sarian Healthcare maintains a quality-focused approach across its product development and business operations.
Reliable Product Supply
Consistent product availability is important for distributors, stockists, pharmacies, and healthcare businesses. Sarian Healthcare works toward maintaining dependable supply and professional coordination.
Diverse Healthcare Product Range
A diverse healthcare product portfolio can help pharmaceutical businesses address different market requirements. Sarian Healthcare continues to develop products across multiple therapeutic categories.
Professional Business Support
Sarian Healthcare aims to provide professional support to distributors, stockists, pharmacies, healthcare professionals, procurement teams, and other healthcare business associates.
Expanding Distribution Network
Sarian Healthcare continues to strengthen its distribution network and develop professional relationships with pharmaceutical distributors and healthcare businesses across different markets.
Long-Term Partnership Approach
Sarian Healthcare focuses on building sustainable relationships with pharmaceutical professionals, distributors, stockists, pharmacies, healthcare companies, and other industry partners.
Sarian Healthcare – Growing Pharmaceutical Partner in India
Sarian Healthcare is working toward strengthening its position in the Indian pharmaceutical market through product development, quality-focused operations, professional service, and an expanding distribution network.
For businesses researching top pharmaceutical companies, pharmaceutical manufacturers, pharma distributors, healthcare companies, or pharmaceutical product suppliers, Sarian Healthcare provides opportunities for professional collaboration.
Businesses searching for a top medicine company in India can evaluate pharmaceutical companies based on product quality, manufacturing capabilities, regulatory compliance, product portfolio, distribution network, supply consistency, and business support.
Sarian Healthcare continues to expand its pharmaceutical portfolio and strengthen its presence in the Indian healthcare and pharmaceutical market.
IPRALITE DUO RESPULES
Composition: Ipratropium 500mcg + Levosalbutamol 1.25mg
Dosage Form: Respule / Nebulizer Solution
Pack Size: 8×5×2.5mL
Manufacturer: Sarian Healthcare









